article thumbnail

Vaccine experts urge more inclusivity in clinical trials

STAT

The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the trials that led to their approval — namely, that older adults were largely left out of them. People who are immunocompromised and those who live in nursing homes were also not included.

Vaccines 334
article thumbnail

Study: Low RSV Vaccination Coverage Among Nursing Home Residents

Pharmacy Times

The study highlights the ongoing need for health care providers to recommend respiratory illness vaccinations to increase protection among nursing home residents during the peak season of infection.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘Worse than what we thought’: New data reveals deeper problems with the Bureau of Prisons’ Covid response

STAT

WASHINGTON — The incarcerated people at Federal Medical Center Devens should have been some of the first to receive the Covid vaccines, back when they first came out in December 2020. At the time, the country was prioritizing high-risk people in high-risk settings, like older Americans in nursing homes.

article thumbnail

STAT+: Pharmalittle: Novartis is losing its chief commercial officer; vaccine experts urge more inclusivity in clinical trials

STAT

The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the clinical trials that led to their approval — namely, that older adults were largely left out of them , STAT tells us.  Among Continue to STAT+ to read the full story…

Vaccines 273
article thumbnail

Study Finds SARS-CoV-2 Booster Vaccination Lowers Infections, Hospitalizations, and Deaths in Nursing Homes

Pharmacy Times

There are limited data on the efficacy of boosters for preventing infection and death in nursing home residents, but the findings suggest that boosters may have significantly reduced COVID-19–associated morbidity and mortality in this population.

article thumbnail

Lilly’s antibody for COVID-19 protection starts nursing home trial

pharmaphorum

While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations. The post Lilly’s antibody for COVID-19 protection starts nursing home trial appeared first on.

article thumbnail

Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims

NY Times

A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.